Brookfield Corp’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,812
Closed -$437K 706
2022
Q3
$437K Buy
+11,812
New +$437K ﹤0.01% 567